APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

MLA

Mandeep Banwait, et al. APOBEC3A Drives Acquired Resistance to Targeted Therapies in Non-Small Cell Lung Cancer. Jan. 2021. EBSCOhost, https://doi.org/10.1101/2021.01.20.426852.

APA

Mandeep Banwait, Pégah Jalili, Jiachen Lin, Heidie Frisco-Cabanos, S. Oh, Nicole Phan, Lee Zou, Zofia Piotrowska, Marcello Stanzione, Daria Timonina, L.V. Sequist, Jeffrey A. Engelman, Varuna Nangia, Rémi Buisson, Faria M. Siddiqui, Rosemary Cobb, Aaron N. Hata, K. Dionne, Jaewon J. Lee, … N. Nikpour. (2021). APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer. https://doi.org/10.1101/2021.01.20.426852

Chicago

Mandeep Banwait, Pégah Jalili, Jiachen Lin, Heidie Frisco-Cabanos, S. Oh, Nicole Phan, Lee Zou, et al. 2021. “APOBEC3A Drives Acquired Resistance to Targeted Therapies in Non-Small Cell Lung Cancer,” January. doi:10.1101/2021.01.20.426852.